Aprameya Engineering Limited
₹90.45▼ -0.85 (-0.93%)
APRAMEYA·NSE·Healthcare
Market Cap
168.12 Cr
PE Ratio
33.75
Volume
30,500
Day High - Low
92.95 - 84.00
52W High-Low
360.00 - 84.00
₹90.45▼ -0.85 (-0.93%)
Market Cap168.12 Cr
PE Ratio33.75
Volume30,500
Day High - Low92.95 - 84.00
52W High-Low360.00 - 84.00
Aprameya Engineering Limited (APRAMEYA): company summary
The company's business has deteriorated significantly, with annual revenue falling 59.4% and annual net profit dropping 68.2%.
Aprameya Engineering Limited (APRAMEYA) is a micro-cap Healthcare company valued at ₹168 crore operating in Medical Equipment & Supplies on the NSE and BSE.
- Recent price move
- Aprameya Engineering Limited last traded at ₹90.45, modestly down 0.93% on the day.
- Recent developments
- On 2026-03-31, the company reported a net loss of ₹2 crore for the latest quarter, marking a reversal from a net profit of ₹18 crore in the same period last year. This indicates a severe contraction in profitability. The company also reported a net profit margin of 9.3%, down 2.6 percentage points from the prior year.
- Financial performance
- The company's business has deteriorated significantly, with annual revenue falling 59.4% and annual net profit dropping 68.2%. The latest quarter saw a sharp decline in revenue, falling 90.0% compared to the same quarter a year earlier, and swung from a net profit of ₹18 crore to a net loss of ₹2 crore.
- Valuation multiples
- The stock trades at 33.8 times earnings, broadly in line with the Healthcare median of 32.0, 2.80 times book value.
- Things to watch
- The company's net profit margin has declined, and it is currently reporting a net loss in the latest quarter. The stock is 71.7% below its 52-week high, and the company has not paid any dividends despite reporting profits. The business has also seen a sharp decline in revenue, with a 90.0% drop in the latest quarter compared to the same quarter a year earlier.
- Where it stands
- Arameya Engineering Ltd has experienced a sharp decline in revenue and profitability, with the latest quarter showing a net loss. The stock is significantly below its 52-week high, and the company has not paid dividends despite reporting profits. The most significant movement is the swing from a net profit of ₹18 crore to a net loss of ₹2 crore in the latest quarter.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
4.3/10
Weak
Fair Value
Sign in to see
ROE
7.35%
Weak
P/E
33.75x
Fair
Debt / Equity
0.10
Low
Industry
Healthcare
Medical Equipment & Supplies
Overall View
Mixed
Price performance
Day₹84.00
₹92.95
52W₹84.00
₹360.00
DocStoX take
Supported by growth (7.6) and risk (6.7), but held back by momentum (0.0). Growth looks strong at 7.6, but that is offset by momentum at 0.0 and valuation at 1.7. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence4.3
/10
Weak
Quality
Modest
ROE 7.4%
Valuation
Expensive
P/E 33.8×
Growth
Strong
Revenue +16.3% 5Y CAGR
Risk
Moderate
D/E 0.10
Momentum
Weak
2% of 52-week range
At a glance
Market Cap
₹168 Cr
52W High / Low
₹360 / ₹84
Dividend Yield
—
Promoter Holding
74.05%
EPS (TTM)
₹2.68
Book Value
₹36.45
Key highlights
- Profit compounding 43% a year
- Low leverage — D/E 0.10
- Profitable in all of the last 5 years
- Valuation is weak (1.7/10)
- Momentum is weak (0.0/10)
4 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Medical Equipment & Supplies
Explore Aprameya Engineering Limited’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Aprameya Engineering Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Aprameya Engineering Limited with peers
Aprameya Engineering Limited vs Sun Pharmaceutical Industries LimitedAprameya Engineering Limited vs Divi's Laboratories LimitedAprameya Engineering Limited vs Torrent Pharmaceuticals LimitedAprameya Engineering Limited vs Apollo Hospitals Enterprise LimitedAprameya Engineering Limited vs Zydus Lifesciences LimitedAprameya Engineering Limited vs Laurus Labs Limited
Related tools & concepts
Value Aprameya Engineering Limited with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing